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Analyses of 2002 National Health Interview supplement on complementary and alternative
medicine (NHIS/CAM) indicate that approximately 38 million adults in the US (18.9% of the
population) used natural herbs or supplements in the preceding 12 months, but only one-third
told their physician about this use. The objectives of this study are: (i) to determine
subpopulation rates of patient–physician communication about herbal product and natural
supplement use and (ii) to identify the relative influence of patient factors and interaction
factors associated with patient-physician communication about herb and supplement use.
Logistic secondary analysis was done by using the complementary and alternative medicine
supplement of the 2002 National Health Interview Survey. Subjects were a random stratified
sample of US adults who used herbs in the past 12 months (n¼5196) and self-reported rates of
disclosure to physicians about herb and supplement use. Results show that disclosure rates were
significantly lower for males, younger adults, racial and ethnic minorities and less intensive
users of medical care. Across subpopulations, disclosure was the exception rather than the
norm. Given the potential risks of delayed or inappropriate treatment and adverse drug
reactions and interactions, physicians should be aware of herb and supplement use and counsel
patients on the potential risks and benefits of these treatments.
Keywords: complementary and alternative medicine–herbal medicine–patient disclosure–
physician–patient communication
A recent national survey indicates that only 33% of
patients who use herbs or supplements discuss this usage
with their physician (1). Using data from the
Complementary and Alternative Medicine supplement
to the 2002 National Health Interview Survey (NHIS/
CAM), the objectives of this secondary analysis are: (i) to
determine subpopulation rates of patient-physician
communication about herbal product and natural supple-
ment use and (ii) to identify the relative influence
of patient factors and interaction factors associated
with patient-physician communication about herb and
supplement use.
The Growing Use of Herbs and Supplements
The use of herbal products and natural supplements is
increasingly common in the US (2). Analyses of 2002
NHIS/CAM indicate that approximately 38 million
adults in the US (18.9% of the population) used natural
herbs or supplements in the preceding 12 months (3). Use
rates are higher for women, middle-aged adults, racial
minorities, college graduates and adults who have
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properly cited.difficulty paying for conventional medical care and
prescription drugs (1).
Clinicians have raised a number of concerns about the
growing popularity of herbs and supplements. While
some of these products appear to be relatively safe and
potentially efficacious (4,5), others can cause adverse
drug reactions (6). Chemical assays of these products
show significant variability in composition and strength
of therapeutic agents (7) and, in some cases, the presence
of dangerous adulterants (8) and contaminants (9).
Use of prescription or over-the-counter medications, in
conjunction with herbal preparations, places patients at
risk for a variety of serious drug interactions (10).
The Problem of Patient Disclosure
American physicians tend to be skeptical of the benefits
of herbs and supplements (11), they rarely use these
products to treat themselves (12) and are unlikely to
recommend them to their patients (13). Nonetheless,
physicians are often called upon to talk and advise their
patients about the risks and benefits of these products
(14–19). Unfortunately, surveys indicate that patient-
physician discussion about the use of herbs and other
complementary and alternative therapies is the exception
rather than the norm. While most CAM users in the US
have regular physicians (20) and say that they want to
discuss their use of non-conventional therapies (21), most
do not (1,22).
Factors Associated with Disclosure
A variety of social, economic and psychologic factors
can influence disclosure of herb and supplement use.
A review of CAM studies and the broader literature
on physician communication (18,23,24) suggest that
disclosure is a function of both patient (25–33) and
physician (11,12,34–39) characteristics. Because the
NHIS/CAM is a population-based survey, this analysis
necessarily focuses exclusively on patient attributes,
including self-reported frequency of interaction with
conventional medical providers (see discussion for study
limitations).
Based on prior CAM research, it is hypothesized that
disclosure is negatively associated with minority group
status (25,32) and positively associated with socioeco-
nomic status (25,26,39). Because patient disclosure
requires regular interaction with medical providers, it is
also hypothesized that herb and supplement users with
more frequent doctor or hospital visits will be more likely
to disclose.
Significance of the Study
Patient disclosure of herb and supplement use to
physicians is an important public health issue. Low
rates of disclosure may place some populations at greater
risk for clinical complications arising from adverse drug
reactions or interactions and from delay or substitution
of appropriate conventional medical treatments. This
study provides the first detailed US national estimates of
patient disclosure about herb and supplements use and
identifies the relative influence of factors associated with
disclosure.
Methods
The National Health Interview Survey (NHIS)
This study uses data from the NHIS, a continuing
household probability survey representative of the civilian
non-institutionalized population of the US conducted by
the Centers for Disease Control’s National Center for
Health Statistics (NCHS). The NHIS is widely regarded
by the research community as the most comprehensive
and current source of population data on health in the
US (40). Various special supplements are administered,
along with the core surveillance items of the NHIS to
address specific policy and population concerns. The
NHIS/CAM is a special supplement to the 2002 Sample
Adult Core (n¼31044).
The NHIS employs a multistage stratified random
sampling strategy. NCHS contractors conduct face-to-
face interviews with an available household member and
enter responses into a handheld computer that codes
conditional responses and performs real-time consistency
checks. Descriptive data on all household members are
collected for the Family Core Survey and an adult is
randomly selected for more detailed questions in the
Sample Adult Core Survey (if there are children in the
household, data are also collected for a randomly selected
child in the Sample Child Core Survey).
The NHIS is a household survey and does not cover
persons living in institutional settings such as military
barracks, prisons, nursing homes, convalescent facilities,
group homes and mental hospitals, and an inference
cannot be made to these populations. According to 2002
NHIS user’s guide,(41) the total household response rate
was approximately 90%. About 7% of the non-interview
rate was the result of respondent refusal and unaccep-
table partial interviews. The remaining 3% were primar-
ily the result of failure to locate an eligible respondent at
home after repeated calls.
NCHS weights, derived from Decennial Census data,
are used to calculate prevalence estimates of patient
disclosure that are generalizable to the US population.
To address concerns regarding sampling error in complex
household surveys, the SUDAAN CROSSTABS proce-
dure was used to generate standard errors for all
estimates (42) and SUDAAN LOGISTIC was used to
calculate adjusted and unadjusted odds ratios and 95%
confidence intervals.
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In the NHIS/CAM survey, 5787 adults answered yes to
the following question: ‘During the past 12 months, did
you use natural herbs for your own health or treatment
(e.g. ginger, echinacea or black cohosh; including teas,
tinctures, and pills)?’ For a detailed profile of herb users
and a description of the type and frequency of herbs
used, see Kennedy (1).
Herb users were asked, ‘During the past 12 months, did
you let any of these conventional medical professionals
know about your use of natural herbs?’ The following
categories of professionals were listed: (i) medical doctor;
(ii) nurse practitioner/physician assistant; (iii) psychiatrist
and (iv) dentist. About 96% of respondents who said
they disclosed herbal product use to one or more
conventional health professionals selected the first
option - medical doctors. Aggregating categories (i) and
(iii) boosts this number slightly, to about 97%. Due to
this response pattern and because of the focus on
physician-patient communication in the clinical literature,
disclosure was operationally defined as follows:
(a) 1¼used herbs in past 12 months and told their
physician (sample n¼1851).
(b) 0¼used herbs in past 12 months and did not tell
their physician (n¼3345).
(c) omitted¼did not use herbs in past 12 months
(n¼25257); used herbs in past 12 months and did
not see a physician (n¼494); used herbs and only
told nurse practitioner, physician assistant, or
dentist (n¼61); refused, not ascertained, or don’t
know (n¼36).
Results
Table 1 shows patient disclosure rates among respondents
who used herbs and saw a physician in the preceding 12
months. Unadjusted (UAOR) and adjusted odds ratios
(AOR) with associated 95% confidence intervals (CI)
were calculated for relevant patient and physician
interaction characteristics of the study population.
Except where noted, this results section will focus on
the full multivariate model and adjusted odds ratios.
Sociodemographic Factors
The logistic model identified a number of demographic
differences in patient disclosure rates. Women were more
likely to discuss herb use with their physician than men
(AOR¼1.2; 95% CI¼1.0–1.4) and so were older adults
(e.g. adults aged 45–64 were 1.6 times more likely to
disclose than those aged 18–24). Black/African American
(AOR¼0.8; 95% CI¼0.6–1.0) and Asian (AOR¼0.5;
95% CI¼1.1–1.4) respondents were less likely to disclose
herb use than white respondents, Hispanics were less
likely to disclose than non-Hispanics (AOR¼0.7; 95%
CI¼0.5–0.9), and non-citizens were less likely to disclose
than citizens (AOR¼0.5; 95% CI¼0.3–0.8).
Socioeconomic Factors
Socioeconomic differences (i.e. family income, education)
in disclosure rates were less pronounced and did not
prove to be significant predictors in the multivariate
model. Adults who were covered under public health
insurance programs (i.e. Medicare and/or Medicaid) were
somewhat more likely to talk about herb use with their
physicians (AOR¼1.4; 95% CI¼1.0–0.8), while people
without insurance were less likely to disclose (AOR¼0.8;
95% CI¼0.6–1.1) than those with private insurance
only.
Health Factors
Adults in poor health were more likely to discuss herb
use with their physicians, but after controlling for other
factors, this predictor was not statistically significant
(AOR¼1.1; 95% CI¼0.8–1.4). Two measures of health
care utilization, number of physician visits and hospita-
lization, were more strongly associated with disclosure,
suggesting that poor health increases use of medical
services, which in turn creates more opportunities to
discuss herb use and possibly greater incentives for doing
so. Adults who had been hospitalized in the past 12
months were 1.4 times more likely to disclose than those
who had not (95% CI¼1.1–1.7). Those who had visited
a physician six or more times in the past year were 1.8
times more likely to disclose herb or supplement use than
those with only one visit (95% CI¼1.4–2.2).
Discussion
This study shows that most Americans who use herbs
and supplements do so in addition to conventional
medical treatment, but only about a third discuss their
decision with a physician. Despite personal or profes-
sional reservations about the efficacy and safety, physi-
cians need to know their patients’ self-treatment regimens
to diagnose and treat them effectively (43,44). Changes in
the type and frequency of patient-physician communica-
tion about herb and supplement use are therefore
required. Understanding the relative rates of non-
disclosure in the patient population can help target
physician and patient interventions.
At-Risk Populations
The finding that frequent or intensive users of conven-
tional medical care were more likely to disclose use of
herbs or supplements was encouraging. Heavy users
eCAM 2008;5(4) 453of conventional medical care are more likely to have
serious or chronic conditions and more likely to take
prescription medications. They are, therefore, presumably
more vulnerable to adverse drug reactions and
interactions, and their treating physicians should be
informed about herb and supplement use. But even in
this critical population, non-disclosure was quite
common. In other groups that tend to have high rates
Table 1. Factors associated with patient disclosure of herb and supplement use among adults who have visited a physician and used herbs in the
preceding 12 months
Disclosure rates Unadjusted OR (95% CI) P Adjusted OR (95% CI) P
Sex P50.001 0.012
Male 31.1% 1.0 reference 1.0 reference
Female 39.4% 1.4 (1.3–1.7) 1.2 (1.0–1.4)
Age P50.001 P50.001
18–24 27.9% 1.0 reference 1.0 referenc
25–44 30.4% 1.1 (0.9–1.5) 1.1 (0.8–1.5)
45–64 41.3% 1.8 (1.4–2.4) 1.6 (1.2–2.1)
 65 49.3% 2.2 (1.6–3.1) 1.5 (1.0–2.2)
Race P50.001 0.001
White 37.4% 1.0 reference 1.0 refernce
Black/African American 31.2% 0.8 (0.6–0.9) 0.8 (0.6–1.0)
Asian 18.4% 0.4 (0.2–0.6) 0.5 (0.3–0.7)
Other Race 25.1% 0.6 (0.4–0.8) 1.1 (0.6–1.8)
Multiple Race 47.4% 1.5 (1.0–2.3) 1.5 (1.0–2.3)
Ethnicity P50.001 0.004
Hispanic 24.8% 0.6 (0.5–0.7) 0.7 (0.5–0.9)
NonHispanic 37.2% 1.0 reference 1.0 reference
Citizenship P50.001 0.002
U.S. Citizen 37.3% 1.0 reference 1.0 reference
Not U.S. Citizen 15.9% 0.3 (0.2–0.4) 0.5 (0.3–0.8)
Education Level 0.223 0.2
High school grad or less (0–12 years) 34.6% 0.9 (0.8–1.1) 0.9 (0.8–1.1)
College (12þ years) 36.7% 1.0 reference 1.0 reference
Annual Family Income 0.042 0.056
$20000 or more 36.4% 1.0 reference 1.0 reference
Less than $20000 31.7% 0.8 (0.7–1.0) 0.8 (0.6–1.0)
Current Insurance Coverage P50.001 0.015
Private health insurance only 35.6% 1.0 reference 1.0 reference
Public health insurance 46.2% 1.6 (1.3–1.8) 1.4 (1.0–1.8)
No health insurance 22.8% 0.5 (0.4–0.7) 0.8 (0.6–1.1)
Self-Assessed Health Status P50.001 0.67
Poor-Fair 44.5% 1.5 (1.2–1.8) 1.1 (0.8–1.4)
Good-Excellent 34.9% 1.0 refernce 1.0 reference
Hospitalized in Past 12 Months P50.001 0.004
Yes 49.4% 1.9 (1.5–2.3) 1.4 (1.1–1.7)
No 34.5% 1.0 reference 1.0 refernce
MD Visits in Past 12 Months P50.001 P50.001
1 30.5% 1.0 reference 1.0 reference
2–5 35.1% 1.2 (1.0–1.5) 1.1 (0.9–1.8)
6 or more 49.1% 2.2 (1.8–2.7) 1.8 (1.4–2.2)
Source: CAM Supplement to the 2002 National Health Interview Survey, National Center for Health Statistics (2003).
Hosmer-Lemeshow Goodness of Fit Test (X
2,P) 11.8 (0.16).
454 Disclosure about herb useof adherence to conventional medical treatment regi-
mens—women, the elderly, college graduates—disclosure
rates were also higher than average, but no group
reached even the 50% level.
Non-disclosure of herb and supplement use was
particularly common among racial and ethnic minority
groups and among non-citizens. Language barriers,
cultural differences and limitations in access to conven-
tional medical care may account for these differences.
Many of these adults have a cultural tradition of
herbalism and are more likely to use herbs and
supplements than the majority population (45–49). High
rates of use, combined with low rates of disclosure, make
these populations particularly vulnerable. Knowledge of
traditional health practices and open discussion of herbal
treatments are therefore critical components of culturally
competent medical care (50–53).
Study Limitations
As noted in the introduction, this study focuses
exclusively on patient attributes, but disclosure is best
seen as a relationship between physicians and patients
(43). Relevant physician attributes would include type
and recency of medical training, medical specialty,
communication style, cultural sensitivity, knowledge of
and attitudes toward complementary and alternative
therapies. The quality as well as the frequency of
interactions should also be considered. Increasingly
short office visits (54), possibly aggravated in the US
by managed care (55), are a source of frustration for both
physicians and patients (56,57). The factors should be
included in any comprehensive research on disclosure.
The NHIS/CAM inclusion criteria for herb use do not
capture important differences in type and intensity of
utilization. As one reviewer noted, aggregating ‘a woman
who uses soy to reduce the number of hot flashes
together with someone who uses scores of different herbs
to treat an array of conditions’ raises some obvious
questions about the relative risk of non-disclosure.
Failure to discuss occasional herb or supplement use,
particularly for preparations with a good safety profile
and proven therapeutic benefit, is not a matter of great
concern. However, the undisclosed and unsupervised use
of multiple herbs and supplements, particularly those that
have not been subject to scientific scrutiny, is a critical
issue for patient safety. Development of reasonably
detailed risk profiles for herbal preparations is an
obvious research priority.
Medical Practice Implications
Patient–physician communication is of pivotal impor-
tance in medical practice (58), and the use of herbs and
other CAM is an important topic of conversation
(18,59,60). In order to discuss CAM with patients,
physicians need to be familiar with common complemen-
tary and alternative treatments. There are calls to add
CAM training to the already crowded medical school
curricula (61,62) as well as efforts to encourage continu-
ing education in this area (34,63,64). Ultimately, a truly
complementary model of health care will involve active
collaboration of patients, conventional medical care
providers and CAM providers (44).
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